Moreover, many inflammatory signaling pathways (i.e., IL-1–6, IL-23, and CRP) depend on a parasympathetic and hypothalamus–pituitary–adrenal (HPA) axis dysregulation, which has been proven to participate in triggering mental disorders, including depression, schizophrenia, and bipolar disorders [20,21]. Here, CRP is linked to depressive symptom measurement.